Venrock Healthcare Capital Partners III, L.P. insider trades
Venrock Healthcare Capital Partners III, L.P. has filed 5 Form 4s with the SEC that we hold, for KALV (10% owner) and Lycia Therapeutics, Inc. (LYCA) (10% owner). Across all of them we count 16 purchases worth $42.9M and 0 sales worth $0 reported on Form 4. In the last 12 months: 6 purchases ($37.7M) and 0 sales ($0). The largest single trade was a purchase of 1,944,444 shares of Lycia Therapeutics, Inc. worth $35.0M, dated 2026-10-26. The first filing on our record is dated 2024-01-10 and the latest 2026-10-27.
KALV
10% owner · 4 filings · 10 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2024-01-08 | P, purchase reported on Form 4 | 69,184 | $860.6K | 2024-01-10 | SEC |
| 2024-01-09 | P, purchase reported on Form 4 | 20,816 | $261.4K | 2024-01-10 | SEC |
| 2024-01-10 | P, purchase reported on Form 4 | 47,700 | $604.4K | 2024-01-10 | SEC |
| 2024-01-25 | P, purchase reported on Form 4 | 7,030 | $89.5K | 2024-01-29 | SEC |
| 2024-01-26 | P, purchase reported on Form 4 | 4,174 | $54.2K | 2024-01-29 | SEC |
| 2024-01-29 | P, purchase reported on Form 4 | 80,600 | $1.1M | 2024-01-29 | SEC |
| 2024-01-30 | P, purchase reported on Form 4 | 88,099 | $1.3M | 2024-02-01 | SEC |
| 2025-02-07 | P, purchase reported on Form 4 | 73,649 | $684.2K | 2025-02-11 | SEC |
| 2025-02-10 | P, purchase reported on Form 4 | 4,137 | $37.8K | 2025-02-11 | SEC |
| 2025-02-11 | P, purchase reported on Form 4 | 26,703 | $245.1K | 2025-02-11 | SEC |
Lycia Therapeutics, Inc. (LYCA)
10% owner · 1 filing · 6 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-10-23 | P, purchase reported on Form 4 | 24,560 | $630.7K | 2026-10-27 | SEC |
| 2026-10-23 | P, purchase reported on Form 4 | 28,379 | $741.0K | 2026-10-27 | SEC |
| 2026-10-26 | P, purchase reported on Form 4 | 1,944,444 | $35.0M | 2026-10-27 | SEC |
| 2026-10-26 | P, purchase reported on Form 4 | 8,261 | $222.8K | 2026-10-27 | SEC |
| 2026-10-27 | P, purchase reported on Form 4 | 8,729 | $225.6K | 2026-10-27 | SEC |
| 2026-10-27 | P, purchase reported on Form 4 | 31,067 | $833.8K | 2026-10-27 | SEC |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1738048) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
